Literature DB >> 31357371

A Raman-based serum constituents' analysis for gastric cancer diagnosis: In vitro study.

Maryam Bahreini1, Ahmad Hosseinzadegan2, Arian Rashidi3, Seyed Rouhollah Miri4, Hamid Reza Mirzaei5, Parastoo Hajian5.   

Abstract

The importance of blood serum testing in most medical diagnosis has led researchers to seek for a reliable analysis method. Raman spectroscopy is a potential tool for probing serum components due to its real-time and non-destructive measurements without need to any additional reagents. So, Raman spectroscopy for the analysis and discrimination of human serum of healthy and gastric cancer subjects is investigated in this work. In order to find the correlation between Raman spectra and enzymatic test results of glucose, cholesterol, HDL, LDL and triglycerides of serum samples, the partial least squares regression (PLSR) method is utilized. Moreover, the Raman spectroscopy is used to distinguish between serum samples of healthy people and gastric cancer patients using partial least square discriminant analysis (PLS-DA) method. Correlation results reveal that for all serum components, the correlation coefficients between Raman spectra and all enzymatic test results are above 94% significantly. Discrimination results of healthy subjects and gastric cancer patients show that 87.5 ± 2.5% of healthy and gastric cancer subjects are diagnosed properly. Our preliminary results can confirm the Raman method in analysis of serum and also as a diagnostic tool in screening of gastric cancer.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Discriminant analysis; Gastric cancer; Partial least squares; Raman spectroscopy; Serum

Year:  2019        PMID: 31357371     DOI: 10.1016/j.talanta.2019.06.068

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  3 in total

1.  In-vitro study on the identification of gastrointestinal stromal tumor tissues using laser-induced breakdown spectroscopy with chemometric methods.

Authors:  Bushra Sana Idrees; Qianqian Wang; M Nouman Khan; Geer Teng; Xutai Cui; Wenting Xiangli; Kai Wei
Journal:  Biomed Opt Express       Date:  2021-12-02       Impact factor: 3.732

2.  Diagnosis of Lung Cancer by FTIR Spectroscopy Combined With Raman Spectroscopy Based on Data Fusion and Wavelet Transform.

Authors:  Xien Yang; Zhongyu Wu; Quanhong Ou; Kai Qian; Liqin Jiang; Weiye Yang; Youming Shi; Gang Liu
Journal:  Front Chem       Date:  2022-01-26       Impact factor: 5.221

3.  Rapid label-free detection of cholangiocarcinoma from human serum using Raman spectroscopy.

Authors:  Peeraya Suksuratin; Rutchanee Rodpai; Vor Luvira; Pewpan M Intapan; Wanchai Maleewong; Oranat Chuchuen
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.